A curated record of the people, institutions, regulatory milestones, clinical programs and manufacturing systems that shaped the development of hemoglobin oxygen carriers and modern oxygen therapeutics.
Biopure and the People Behind an Early Oxygen-Therapeutics Platform
A people-first history of the institutional network that carried a difficult biotechnology program from process engineering and industrial manufacturing to regulatory translation and clinical use.
Carl W. Rausch · David N. Judelson · Theodore Cooper · C. Everett Koop · Charles A. Sanders · Joachim Schnell
Read the full article →Hemopure, Oxyglobin and the early oxygen-therapeutics platform
A concise source note highlighting the report's record of South Africa's Hemopure approval, advanced human clinical development, Oxyglobin's veterinary regulatory history, manufacturing scale-up and the early recognition of blood-storage and prehospital logistics as an oxygen-delivery problem.
BHOC · Hemopure · HBOC-201 · Oxyglobin · acute anemia · prehospital transfusion · trauma · oxygen delivery · Oxygen Bridge
Open historical source note →Hemopure, prehospital trauma and military oxygen-delivery research
A concise source note on the FDA BLA review, South Africa experience, 22-trial Hemopure program, prehospital and ambulance trauma development, Army funding, Navy collaboration, Oxyglobin veterinary use and manufacturing scale-up.
BHOC · HBOC-201 · Hemopure · Oxyglobin · prehospital · ambulance · hemorrhagic shock · Army · Navy · Air Force · trauma resuscitation
Open historical source note →RESUS · Naval Medical Research Center · Biopure
A compact source record of the battlefield need, congressional recommendation, Army grant, Navy research agreement, FDA clinical hold and later planned protocols. Dates, amounts and document types are kept distinct.
Hemopure / HBOC-201 · historical research · not U.S. marketing approval
Open dates and primary documents →These records connect the historical oxygen-therapeutics story to documented regulatory milestones across human and veterinary use. Historical approval is not the same as current product availability or approval of a future BHOC formulation.
This archive separates company-reported historical material from regulatory, institutional and peer-reviewed sources. Historical annual reports can document what was developed, tested, manufactured and claimed at a particular moment, but they are not treated as current clinical guidance or as independent validation of every company statement.
Return to BHOC Evidence Platform →